Inventor · disambiguated record
John M. Sanders
Also filed as: SANDERS JOHN · SANDERS JOHN M
18 granted patents·5 pending applications·66 citations·filing 2005–2019
92Inventor score
Top patents by PatentIndex Score
23 records- 0191US9969749B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted May 15, 2018·6 cites·4 claims
- 0290US9932350B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Apr 3, 2018·5 cites·5 claims
- 0388US9943516B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Apr 17, 2018·5 cites·8 claims
- 0488US9926330B2Inhibitors of IRAK4 activityMERCK SHARP & DOHME·Filed 2015·Granted Mar 27, 2018·5 cites·5 claims
- 0588US7745422B2Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseasesUNIV ILLINOIS·Filed 2008·Granted Jun 29, 2010·11 cites·27 claims
- 0687US7358361B2Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseasesUNIV ILLINOIS·Filed 2005·Granted Apr 15, 2008·10 cites·12 claims
- 0782US7687482B2Bisphosphonate compounds and methodsUNIV ILLINOIS·Filed 2007·Granted Mar 30, 2010·6 cites·19 claims
- 0881US8071573B2Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseasesSANDERS JOHN M·Filed 2010·Granted Dec 6, 2011·5 cites·39 claims
- 0978US9861620B2Substituted quinolizine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jan 9, 2018·3 cites·27 claims
- 1076US10201533B2Substituted quinolizine derivatives useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Feb 12, 2019·1 cites·11 claims
- 1176US9840481B2Allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 12, 2017·2 cites·38 claims
- 1276US9707234B2Spirocyclic hetercycle compounds useful as HIV integrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Jul 18, 2017·2 cites·19 claims
- 1371US9440952B2Compounds inhibiting leucine-rich repeat kinase enzyme activityMERCK SHARP & DOHME·Filed 2014·Granted Sep 13, 2016·1 cites·19 claims
- 1470US9181261B2TrkA kinase inhibitors, compositions and methods thereofMERCK SHARP & DOHME·Filed 2013·Granted Nov 10, 2015·2 cites·12 claims
- 1562US9233977B2Leucine-rich repeat kinase enzyme activityMCCAULEY JOHN A·Filed 2011·Granted Jan 12, 2016·1 cites·15 claims
- 1660US9102673B2Substituted pyrrolo[3,2-c]pyridines as TrkA kinase inhibitorsHANNEY BARBARA·Filed 2012·Granted Aug 11, 2015·1 cites·14 claims
- 1751US2010113415A1Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancerRAJAPAKSE HEMAKA A·Filed 2009·Application pending·0 cites
- 1847US2010197688A1Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancerNANTERMET PHILIPPE G·Filed 2009·Application pending·0 cites
- 1945US2019374526A1Substituted Heterocyclic Compounds as Inhibitors of PRDM9MERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 2043US10233193B2Fused tricyclic heterocyclic compounds useful for treating HIV infectionMERCK SHARP & DOHME·Filed 2016·Granted Mar 19, 2019·0 cites·19 claims
- 2143US2015203512A1Macrocyclic compounds as hiv integrase inhibitorsMERCK SHARP & DOHME·Filed 2013·Application pending·0 cites
- 2241US10870630B2Substituted bicyclic heteroaryl allosteric modulators of nicotinic acetylcholine receptorsMERCK SHARP & DOHME·Filed 2017·Granted Dec 22, 2020·0 cites·13 claims
- 2338US2013338106A1Compounds inhibiting leucine-rich repeat kinase enzyme activityMCCAULEY JOHN A·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John M. Sanders files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →